Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Daebongls Co Ltd

+ Add to Watchlist

078140:KS

13,050 KRW 800 5.78%

As of 02:28:54 ET on 05/04/2015.

Snapshot for Daebongls Co Ltd (078140)

Open: 13,900 Day's Range: 12,650 - 14,050 Volume: 399,582
Previous Close: 13,850 52wk Range: 5,170 - 17,900 1-Yr Rtn: +139.51%

Stock Chart for 078140

No chart data available.
  • 078140:KS 12,950
  • 1D
  • 1M
  • 1Y
13,850
Interactive 078140 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 078140

Current P/E Ratio (ttm) 26.5784
Estimated P/E(12/2015) 21.0885
Relative P/E vs. KOSPI 0.7779
Earnings Per Share (KRW) (ttm) 491.0000
Est. EPS (KRW) (12/2015) 618.8200
Est. PEG Ratio -
Market Cap (M KRW) 144,679.86
Shares Outstanding (M) 11.09
30 Day Average Volume 835,574
Price/Book (mrq) 2.9776
Price/Sale (ttm) 2.7742
Dividend Indicated Gross Yield 0.38%
Cash Dividend (KRW) 50.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth 14.87%
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 078140

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 078140

DAEBONGLS Co., Ltd. manufactures various raw materials for pharmaceuticals, cold permanent, wave, cosmetics, and food additives. The Company's product includes cefaclor, thiomin-ns, silymarine, and erdostein. DAEBONGLS provides products for pharmaceutical and cosmetic manufacturing companies.

Park Jong-HoCo-CEO/Co-Rep DirectorPark Jin-HoCo-CEO/Co-Rep Director
Kim Yong-GilManaging Director
More Company Profile & Key Executives for 078140

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil